Back to Journals » Cancer Management and Research » Volume 12
Review
Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,234 | Dovepress* | 6,974+ | 1,197 | 8,171 | |
PubMed Central* | 4,260 | 653 | 4,913 | ||
Totals | 11,234 | 1,850 | 13,084 | ||
*Since 17 August 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar